ArticleCancer management and research2021

Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor.

Yalin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.